"Peter—we got it. We got BioLa."
I felt satisfaction settle in my chest. "Your father agreed to the other leverage structure I gave you that wasn't part of the main solutions?"
"Every single point you outlined." Papers rustled on her end. "The equity partnership model, the phased milestone payments tied to their FDA approval timeline, the performance-based fee escalation—he presented it exactly as you structured it. Darlus Construction couldn't match it. They were still operating on the traditional fixed-fee model."
"Of course they were. Darlus thinks in quarters, not decades. They never understood that BioLa's real value isn't the facility—it's positioning Torres Development as the premier builder for biotech research infrastructure on the West Coast."
